BRTX

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

BioRestorative Therapies Inc

NASDAQ | BRTX

1.04

USD

+$0.00

(

+0.00%

)

At Close (As of Dec 2, 2025)

$9.05M

Market Cap

-

P/E Ratio

-1.46

EPS

$2.55

52 Week High

$0.98

52 Week Low

HEALTHCARE

Sector

BRTX Chart

Recent Chart
Price Action

BRTX Technicals

Tags:

BRTX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $373K
Total Revenue $401K
Cost Of Revenue $28K
Costof Goods And Services Sold $28K
Operating Income -$12M
Selling General And Administrative $6.6M
Research And Development $5.3M
Operating Expenses $12M
Investment Income Net -
Net Interest Income $616K
Interest Income $616K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $189K
Income Before Tax -$9M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$9M
Comprehensive Income Net Of Tax -
Ebit -$12M
Ebitda -$11M
Net Income -$9M

Revenue & Profitability

Earnings Performance

BRTX Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $12M
Total Current Assets $11M
Cash And Cash Equivalents At Carrying Value $548K
Cash And Short Term Investments $548K
Inventory -
Current Net Receivables $188K
Total Non Current Assets $1.1M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $624K
Intangible Assets Excluding Goodwill $624K
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $10M
Other Current Assets $223K
Other Non Current Assets -
Total Liabilities $3.7M
Total Current Liabilities $3.7M
Current Accounts Payable $483K
Deferred Revenue -
Current Debt -
Short Term Debt $325K
Total Non Current Liabilities $0
Capital Lease Obligations $0
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $162K
Other Current Liabilities $3.3M
Other Non Current Liabilities -
Total Shareholder Equity $8.5M
Treasury Stock -
Retained Earnings -$156M
Common Stock $692
Common Stock Shares Outstanding $7.8M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$8.2M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $189K
Capital Expenditures $106K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $515K
Cashflow From Financing $7.4M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout $624K
Dividend Payout Common Stock $624K
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$9M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $373K
Total Revenue $401K
Cost Of Revenue $28K
Costof Goods And Services Sold $28K
Operating Income -$12M
Selling General And Administrative $6.6M
Research And Development $5.3M
Operating Expenses $12M
Investment Income Net -
Net Interest Income $616K
Interest Income $616K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $189K
Income Before Tax -$9M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$9M
Comprehensive Income Net Of Tax -
Ebit -$12M
Ebitda -$11M
Net Income -$9M

BRTX News

BRTX Profile

BioRestorative Therapies Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

BioRestorative Therapies Inc. (BRTX), based in Melville, New York, is at the forefront of regenerative medicine, specializing in the development of innovative therapies leveraging adult stem cell technology. The company's mission is to meet significant unmet medical needs by delivering safe and effective treatments across key therapeutic areas such as orthopedics and neurology. With a commitment to advancing cellular and tissue-based methodologies, BRTX aims to play a vital role in the transformation of healthcare solutions, positioning itself as a key player in the evolving regenerative medicine landscape.

LPTX
+368.57%
$2.05
PAVS
-29.35%
$0.05
NVDA
+0.85%
$181.46
VHAI
0.00%
$0.00
PLUG
+9.89%
$2.11
CMND
-9.93%
$0.12
TWOH
0.00%
$0.00
BITF
-5.48%
$3.10
ONDS
+6.46%
$8.07
IPG
-1.95%
$24.57
AXDX
-61.36%
$0.03
AAL
+2.00%
$14.24
ASST
-1.42%
$1.03
BMNR
+10.26%
$31.91
F
-1.51%
$12.96
AAPL
+1.09%
$286.19
ADAP
-15.14%
$0.05
WBD
+2.76%
$24.53
MARA
+3.38%
$11.91
BAC
-0.09%
$53.19
DNN
+2.77%
$2.59
PFE
-0.47%
$25.15
NIO
-2.89%
$5.03
SOND
-23.45%
$0.12
BMNU
+19.54%
$7.34
AMD
-2.05%
$215.24
CAN
+2.04%
$0.96
YGMZ
-21.06%
$0.08
CLSK
-2.62%
$13.71
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ABEV
+0.38%
$2.58
MRVL
+1.96%
$92.89
ADD
-25.47%
$0.05
IVP
-0.62%
$0.12
ITUB
+2.64%
$7.89
GOOGL
+0.29%
$315.81
PLTR
+1.91%
$170.69
SRM
+53.27%
$10.30
GRAB
-0.18%
$5.26
APLD
-0.56%
$28.05
EXK
-1.70%
$9.24
INHD
-15.40%
$0.14
BQ
+41.53%
$2.76
MSTR
+5.78%
$181.33
PLTD
-1.83%
$6.96
VALE
+1.57%
$12.89
EB
+78.62%
$4.43
RGTI
+1.83%
$23.88
BURU
-0.76%
$0.21
WLGS
-5.57%
$0.04
ASBP
+1.11%
$0.09
MTSR
-0.35%
$70.50
RIG
-0.91%
$4.31
NFLX
+0.20%
$109.35
PCG
-3.28%
$15.32
CRWV
-1.33%
$76.03
HOOD
+2.19%
$125.95
IXHL
+12.12%
$0.39
GOOG
+0.28%
$316.02
CHR
-0.91%
$0.04
GPUS
+6.45%
$0.28
VICI
-0.48%
$28.45
AFMD
-34.94%
$0.18
VZ
-0.31%
$40.61
BA
+10.14%
$205.38
AG
+2.51%
$15.91
AVGO
-1.16%
$381.57
RIOT
-1.67%
$15.22
STLA
+2.81%
$10.95
VCIG
+0.95%
$1.06
NOK
+1.14%
$6.19
LUMN
+10.25%
$9.14
QBTS
+5.04%
$22.50
TAOP
+32.71%
$2.84
AMCR
-1.63%
$8.40
ORCL
+0.07%
$201.10
MSFT
+0.66%
$490.00
CGC
-1.76%
$1.11
SMCI
-1.46%
$32.92
SMR
+4.59%
$18.91
GRYP
-10.38%
$1.38
UBER
+1.15%
$87.57
EOSE
-6.06%
$12.78
MODV
-25.22%
$0.43
TSLG
-0.64%
$9.21
CCL
-0.34%
$25.84
IQ
-3.34%
$2.02
ALAB
-13.46%
$142.94
RXRX
-0.91%
$4.32
JOBY
+2.67%
$13.83
AMC
-2.12%
$2.30
AEO
-1.97%
$20.83
PLTZ
-3.85%
$6.99
CRDO
+10.11%
$188.44
HPE
-0.09%
$21.92
XPEV
-7.91%
$19.66
CRCL
+1.97%
$77.44
AKTX
-14.10%
$0.34
PG
-1.07%
$145.86
LPTX
+368.57%
$2.05
PAVS
-29.35%
$0.05
NVDA
+0.85%
$181.46
VHAI
0.00%
$0.00
PLUG
+9.89%
$2.11
CMND
-9.93%
$0.12
TWOH
0.00%
$0.00
BITF
-5.48%
$3.10
ONDS
+6.46%
$8.07
IPG
-1.95%
$24.57
AXDX
-61.36%
$0.03
AAL
+2.00%
$14.24
ASST
-1.42%
$1.03
BMNR
+10.26%
$31.91
F
-1.51%
$12.96
AAPL
+1.09%
$286.19
ADAP
-15.14%
$0.05
WBD
+2.76%
$24.53
MARA
+3.38%
$11.91
BAC
-0.09%
$53.19
DNN
+2.77%
$2.59
PFE
-0.47%
$25.15
NIO
-2.89%
$5.03
SOND
-23.45%
$0.12
BMNU
+19.54%
$7.34
AMD
-2.05%
$215.24
CAN
+2.04%
$0.96
YGMZ
-21.06%
$0.08
CLSK
-2.62%
$13.71
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ABEV
+0.38%
$2.58
MRVL
+1.96%
$92.89
ADD
-25.47%
$0.05
IVP
-0.62%
$0.12
ITUB
+2.64%
$7.89
GOOGL
+0.29%
$315.81
PLTR
+1.91%
$170.69
SRM
+53.27%
$10.30
GRAB
-0.18%
$5.26
APLD
-0.56%
$28.05
EXK
-1.70%
$9.24
INHD
-15.40%
$0.14
BQ
+41.53%
$2.76
MSTR
+5.78%
$181.33
PLTD
-1.83%
$6.96
VALE
+1.57%
$12.89
EB
+78.62%
$4.43
RGTI
+1.83%
$23.88
BURU
-0.76%
$0.21
WLGS
-5.57%
$0.04
ASBP
+1.11%
$0.09
MTSR
-0.35%
$70.50
RIG
-0.91%
$4.31
NFLX
+0.20%
$109.35
PCG
-3.28%
$15.32
CRWV
-1.33%
$76.03
HOOD
+2.19%
$125.95
IXHL
+12.12%
$0.39
GOOG
+0.28%
$316.02
CHR
-0.91%
$0.04
GPUS
+6.45%
$0.28
VICI
-0.48%
$28.45
AFMD
-34.94%
$0.18
VZ
-0.31%
$40.61
BA
+10.14%
$205.38
AG
+2.51%
$15.91
AVGO
-1.16%
$381.57
RIOT
-1.67%
$15.22
STLA
+2.81%
$10.95
VCIG
+0.95%
$1.06
NOK
+1.14%
$6.19
LUMN
+10.25%
$9.14
QBTS
+5.04%
$22.50
TAOP
+32.71%
$2.84
AMCR
-1.63%
$8.40
ORCL
+0.07%
$201.10
MSFT
+0.66%
$490.00
CGC
-1.76%
$1.11
SMCI
-1.46%
$32.92
SMR
+4.59%
$18.91
GRYP
-10.38%
$1.38
UBER
+1.15%
$87.57
EOSE
-6.06%
$12.78
MODV
-25.22%
$0.43
TSLG
-0.64%
$9.21
CCL
-0.34%
$25.84
IQ
-3.34%
$2.02
ALAB
-13.46%
$142.94
RXRX
-0.91%
$4.32
JOBY
+2.67%
$13.83
AMC
-2.12%
$2.30
AEO
-1.97%
$20.83
PLTZ
-3.85%
$6.99
CRDO
+10.11%
$188.44
HPE
-0.09%
$21.92
XPEV
-7.91%
$19.66
CRCL
+1.97%
$77.44
AKTX
-14.10%
$0.34
PG
-1.07%
$145.86
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.